Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis.

• Meets the diagnostic criteria for fungal-sensitized asthma.

Locations
Other Locations
China
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
RECRUITING
Jinan
Contact Information
Primary
Qian Qi, Prof.
qiqianqlh@163.com
+86 13706380314
Time Frame
Start Date: 2025-05-10
Estimated Completion Date: 2029-01-31
Participants
Target number of participants: 140
Treatments
allergic bronchopulmonary aspergillosis
fungal-sensitized asthma
control group
Sponsors
Leads: Qianfoshan Hospital
Collaborators: Qilu Hospital of Shandong University, Guizhou Provincial People's Hospital, Fudan University, Shanghai Pulmonary Hospital, Tongji University School of Medicine, The First Hospital of Jilin University

This content was sourced from clinicaltrials.gov